Xu Liang, Jiang Xifeng, Xu Xiaoyu, Zheng Baohua, Chen Xueliang, Zhang Tao, Gao Fang, Cai Lifeng, Cheng Maosheng
Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, China.
MOE Key Laboratory of Structure-Based Drug Design & Discovery, Shenyang Pharmaceutical University, 103 Wenhua Rd, Shenhe District, Shenyang 110016, China.
Eur J Med Chem. 2014 Jul 23;82:341-6. doi: 10.1016/j.ejmech.2014.05.068. Epub 2014 May 29.
Discovery of new drugs for the treatment of AIDS that possess unique structures associated with novel mechanisms of action are of great importance due the rapidity with which drug-resistant HIV-1 strains evolve. Recently we reported on a novel class of DNA duplex-based HIV-1 fusion inhibitors modified with hydrophobic groups. The present study describes a new category of hairpin fusion inhibitor DNA duplexes bearing a 3 nucleotide loop located at either the hydrophobic or hydrophilic end. The new loop structures were designed to link 2 separate duplex-forming oligodeoxynucleotides (ODNs) to make helix-assembly easier and more thermally stable resulting in a more compact form of DNA duplex based HIV-1 fusion inhibitors. A series of new hairpin duplexes were tested for anti-HIV-1 cell-cell membrane fusion activity. In addition, Tm, CD, fluorescent resonance energy transfer assays, and molecular modeling analyses were carried out to define their structural activity relationships and possible mechanisms of action.
鉴于耐药性HIV-1毒株快速演变,发现具有与新作用机制相关的独特结构的治疗艾滋病新药至关重要。最近我们报道了一类经疏水基团修饰的新型基于DNA双链体的HIV-1融合抑制剂。本研究描述了一类新的发夹融合抑制剂DNA双链体,其在疏水或亲水末端带有一个3核苷酸环。新的环结构旨在连接2个单独的形成双链体的寡脱氧核苷酸(ODN),使螺旋组装更容易且热稳定性更高,从而产生更紧凑形式的基于DNA双链体的HIV-1融合抑制剂。测试了一系列新发夹双链体的抗HIV-1细胞-细胞膜融合活性。此外,还进行了熔点、圆二色光谱、荧光共振能量转移分析以及分子模拟分析,以确定它们的构效关系和可能的作用机制。